Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

Leboulleux, Sophie; Deandreis, Désirèe; Ghuzlan, A. Al; Aupérin, Anne; Goéré, D.; Dromain, Clarisse; Élias, Dominique; Caillou, Bernard; Travagli, Jean-Paul; Baère, Thierry De; Lumbroso, J.; Young, Jacques; Schlumberger, M.; Baudin, Éric

doi:10.1530/eje-09-1096

Cited by 128 publications

(89 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Later on, the same group published their results when they did a head-to-head comparison of laparoscopic and robotic PRA on 31 patients each. Although the mean (standard error of the mean, SEM) OR time was similar in both the groups, there was a significant difference in the mean (SEM) OR time of the last 21 cases of robotic-assisted PRA when compared to the laparoscopic group (139.1 [10.9] [40][41][42][43][44] Robotic adrenalectomy has so far been mainly performed for benign diseases, but it has also been reported for adrenal cancer, adrenal metastasis and oncocytoma. [45][46][47] Recent advances in robotic adrenalectomy Single-port surgery 48 Arghami et al described their experience of performing single-port RA in 16 patients and did a matched cohort analysis with 16 patients of LA.…”

Section: Posterior Retroperitoneoscopic Adrenalectomy (Pra)mentioning

confidence: 99%

Robot-assisted adrenalectomy: current perspectives

Pahwa¹

2017

RSRR

View full text Add to dashboard Cite

Laparoscopy has established itself as the procedure of choice for performing adrenalectomy in benign adrenal disorders. Although laparoscopy scores heavily over open approach in terms of lesser blood loss, pain, shorter hospital stay and better cosmesis, it is riddled with certain shortcomings such as the need of dexterity, two-dimensional vision, dependence on an assistant for camera, etc. Robotic surgery promises to overcome these limitations. Multiple series have established that robotic adrenalectomy is a safe and effective procedure as conventional laparoscopy. Recently, robotic surgery has been found to be precise and accurate in performing partial adrenalectomy in hereditary adrenal syndrome cases. Other advances like single-port surgery have expanded the horizon and indications of robotic surgery. This review aims at studying the current evidence available for the effectiveness of robot-assisted adrenalectomy and defining its current status in managing adrenal disorders.

show abstract

Section: Posterior Retroperitoneoscopic Adrenalectomy (Pra)mentioning

confidence: 99%

Robot-assisted adrenalectomy: current perspectives

Pahwa¹

2017

RSRR

View full text Add to dashboard Cite

show abstract

“…Three recent studies have reported a higher risk of peritoneal carcinomatosis associated with laparoscopic resection vs open adrenalectomy in ACC surgery (22)(23)(24). However, all these studies were retrospective in nature and included few patients with laparoscopic approach.…”

Section: Discussionmentioning

confidence: 99%

Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumor

Lepoutre-Lussey

Rousseau²,

Ghuzlan³

et al. 2012

European Journal of Endocrinology

View full text Add to dashboard Cite

Context: Primary adrenal angiosarcoma is an extremely rare neoplasm, as are combined tumors within a given adrenal lesion. Clinical presentation and intervention: A 35-year-old man presented with hypokalemic hypertension leading to the discovery of a 6 cm diameter malignant-appearing right adrenal tumor. The lesion displayed marked 18 F-fluorodeoxyglucose uptake on positron emission tomography scanning. Endocrine investigations revealed secretion of both cortisol and aldosterone by the neoplasm. The entire right adrenal gland along with the periadrenal fat tissue was removed during laparoscopic surgery. Results: Histological examination revealed two intermingled tumor cell proliferations, namely an angiosarcoma and an adrenocortical adenoma. An extensive post-operative search revealed no other primary tumor site, nor metastases. The lesion was then considered to be a primary adrenal angiosarcoma combined with a secreting adrenocortical adenoma. The patient received four cycles of chemotherapy (adriamycin/ifosfamide). At 2-year follow-up, he is alive and well, with no sign of relapse. Conclusion: To the best of our knowledge, this is the first case of an adrenal neoplasm combining a primary angiosarcoma and a functioning adrenocortical adenoma.

show abstract

“…Bununla birlikte, laparoskopik cerrahi sonrası peritoneal nüks ve karsinomatozis gelişiminin açık adrenalektomiye göre daha fazla saptanması nedeniyle, genel yaklaşım adrenokortikal karsinomda açık adrenalektominin yapılmasıdır [10,11].…”

Section: Cerrahiunclassified